✦ LIBER ✦

Phase II study of topotecan (TOP) for relapsed small cell lung cancer (SCLC)

✍ Scribed by Ogawara, M; Negoro, S; Nishiwaki, Y; Fukuoka, M; Watanabe, K; Niitani, H

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Late phase II trials of topotecan (T) fo

✍ Y. Nishiwaki; S. Negoro; K. Watanabe; M. Fukuoka; H. Niitani 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 162 KB

84 Phase II study of topotecan in refrac

✍ A. Ardizzoni; H.H. Hansen; P. Dombernowsky; S. Kaplan; P.E. Postmus; T. Gamucci; 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 159 KB

A Phase II Study of Higher Dose Weekly T

✍ David R. Spigel; F. Anthony Greco; Howard A. Burris III; Dianna L. Shipley; Bobb 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 318 KB

Treatment of small cell lung cancer (SCL

✍ Morales, S; Balil, A; Salud, A; Antonio Carceller, J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Paclitaxel and gemcitabine for refractor

✍ M. Domine; J. Gonzalez Larriba; R. Garcia Gomez; S. Morales; D. Isla; C. Garcia 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 339 KB

Randomised Phase II study of topotecan/c

✍ Gervais, R; Quoix, E; Mattson, K; Schramel, F.M; Rivière, A; Fields, S; Wheatley 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB